Abstract
Summary
The intensive arsenical therapy used in the 5-day treatment of syphilis produces no demonstrable effect on the bone marrow of patients who have no individual idiosyncrasy to arsenical drugs. Cases of primary and secondary syphilis in which there is no change in the peripheral blood picture have a distribution of cell types in the bone marrow which is within the normal limits of variation.
Get full access to this article
View all access options for this article.